drugset / Trial / NCT05882903

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

NCT05882903

Phase 2 Recruiting 24 enrolled Oticara Australia PTY LTD
NaSingle-groupOpen-labelTreatment

Summary

To assess the safety and efficacy of one (single) application of Betamethasone Dipropionate Nasal Cream (BMDP CREAM) onto the sinus mucosa.

Timeline

Start
2023-08-17
Primary completion
2025-06-01
Completion
2025-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject betamethasone dipropionate Small molecule 10 g Topical